Mortality in mechanical ventilation in prone position in patients with acute respiratory distress síndrome
DOI:
https://doi.org/10.56294/shp2025224Keywords:
Respiratory distress syndrome, adult, Prone position, Meta-analysisAbstract
Introduction: Prone ventilation has been shown to improve oxygenation and lung mechanics in patients with acute respiratory distress syndrome, but I consider it necessary to delve deeper into the relationship between the prone position and mortality. Objectives: To evaluate whether the prone position decreases the risk of mortality in adult patients with acute respiratory distress syndrome vs. supine ventilation, in a global and segmented manner, as well as to know the main adverse effects related to it. Material and methods: A meta-analysis of randomized controlled clinical trials comparing patients in the prone vs. supine position was performed with a search in Pubmed, Embase, Cochrane Library and LILACS, and mortality, hospital stay, days of mechanical ventilation and adverse effects were evaluated. Results: Seven randomized controlled clinical trials were included in the analysis. The prone position showed a non-significant tendency to decrease mortality when analyzed globally. When stratified by subgroups, a significant decrease in the risk of mortality was found in patients: 1) ventilated with low tidal volume, 2) prolonged prone position, and 3) established before 48 hours of disease progression in severe hypoxemia. The adverse effects related to prone position were the development of pressure ulcers and orotracheal tube obstruction.
Conclusion: Prone position ventilation is a safe strategy and reduces mortality in patients with severe oxygenation impairment. It should be established early, for prolonged periods, and associated with a protective ventilation strategy.
References
Kliegman RM, Blum NJ, Shah SS, St Geme JW III, Tasker RC, Wilson KM. Nelson Tratado de Pediatría. 21.ª ed. Elsevier; 2020.
Fernández G, Amelotti L, Nicolau V, Vallone A, Altschuler A, Buoro E, et al. Informe Encefalitis Equina del Oeste. Boletín Epidemiológico Nacional. 2024;(702).
Liu Y, Thaker H, Wang C, Xu Z, Dong M. Diagnosis and treatment for Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome. Toxins (Basel) [Internet]. 2022 Jan 1 [cited 2024 Oct 22];15(1):10. Available from: https://www.mdpi.com/2072-6651/15/1/10
Fakhouri F, Schwotzer N, Frémeaux-Bacchi V. How I diagnose and treat atypical hemolytic uremic syndrome. Blood. 2023 Mar 2;141(9):984–95.
Oderiz S, Leotta GA, Galli L. Detección y caracterización de Escherichia coli productor de toxina Shiga en niños atendidos en un hospital pediátrico interzonal de la ciudad de La Plata. Rev Argent Microbiol [Internet]. 2018 [cited 2024 Oct 22];50(4):341–50. Available from: https://www.elsevier.es/es-revista-revista-argentina-microbiologia-372
Boyer O, Niaudet P. Hemolytic uremic syndrome: new developments in pathogenesis and treatment. Int J Nephrol. 2011;2011:908320.
Eymann A, Coccia P, Raddavero C, Lafi G, Ferraris V, Ramírez J, et al. Prevalence and clinical course of typical hemolytic uremic syndrome among siblings. Arch Argent Pediatr. 2016 Dec;114(6):549–56.
Belardo M. Epidemiological surveillance: caught up in the instrumental logic. The case of Hemolytic Uremic Syndrome in Argentina [Internet]. Buenos Aires; 2013 Mar. Available from: http://www.ea-journal.com
Ministerio de Salud de la Nación. Programa Nacional de Prevención del Síndrome Urémico Hemolítico. Buenos Aires: Ministerio de Salud; [s.f.].
Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T, et al. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome. Pediatr Nephrol [Internet]. 2020;35:1749–59. Available from: https://link.springer.com/article/10.1007/s00467-020-04564-5
Ministerio de Salud de la Nación. Campaña Nacional de Prevención del Síndrome Urémico Hemolítico: Importancia, Prevención y Seguimiento. Buenos Aires: Ministerio de Salud; [s.f.].
Eymann A, Coccia P, Raddavero C, Lafi G, Ferraris V, Ramírez J, et al. Prevalencia y evolución clínica del síndrome urémico hemolítico típico entre hermanos. Arch Argent Pediatr [Internet]. 2016 Dec [cited 2024 Oct 29];114(6):553–6. Available from: https://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-00752016000600013
Fernandez-Brando RJ, Bentancor LV, Mejías MP, Panek AC, Cabrera GG, Exeni RA, et al. Escherichia coli productor de toxina Shiga. Medicina (B Aires). 2011;71:383–9.
Published
Issue
Section
License
Copyright (c) 2025 Leila Vanela López, Jorge Eduardo Larcamon (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.